Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

Intravacc offers state-of-the-art analytical methods for identity, content, purity, structure, formulation, stability, and preclinical ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Reasons for Hope Compared to a decade ago, there are substantially more drugs (a 35% increase) being tested for Alzheimer’s ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...

The U.S. Food and Drug Administration (FDA) announced on Wednesday (October 29) a plan to streamline the approval process for biosimilars, which are generic versions of complex biological drugs. These ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

A post hoc analysis of a study investigating drugs containing semaglutide, such as Ozempic and Wegovy, in those living with ...

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating ...